Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic and phosphoproteomic characteristics of the cortex, hippocampus, thalamus, lung, and kidney in COVID-19-infected female K18-hACE2 mice. | EBioMedicine | 2023 | 36933413 | PubTator, text mining | PubMed |
| A central chaperone-like role for 14-3-3 proteins in human cells. | Mol Cell | 2023 | 36931259 | PubTator, text mining | PubMed |
| Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics. | Biomed Pharmacother | 2023 | 36916400 | PubTator, text mining | PubMed |
| Natural Products in Precision Oncology: Plant-Based Small Molecule Inhibitors of Protein Kinases for Cancer Chemoprevention. | Nutrients | 2023 | 36904191 | PubTator, text mining | PubMed |
| Pediatric Acute Lymphoblastic Leukemia Emerging Therapies-From Pathway to Target. | Int J Mol Sci | 2023 | 36902091 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting. | Int J Mol Sci | 2023 | 36901733 | PubTator, text mining | PubMed |
| The Preparation and Potential Bioactivities of Modified Pectins: A Review. | Foods | 2023 | 36900531 | PubTator, text mining | PubMed |
| Primary diffuse Rosai-Dorfman disease in central airway: a case report and literature review. | BMC Pulm Med | 2023 | 36894897 | PubTator, text mining | PubMed |
| Analysis of context-specific KRAS-effector (sub)complexes in Caco-2 cells. | Life Sci Alliance | 2023 | 36894174 | PubTator, text mining | PubMed |
| Analyzing the interactome of human CK2β in prostate carcinoma cells reveals HSP70-1 and Rho guanin nucleotide exchange factor 12 as novel interaction partners. | FASEB Bioadv | 2023 | 36876296 | PubTator, text mining | PubMed |
| PRRC2 proteins impact translation initiation by promoting leaky scanning. | Nucleic Acids Res | 2023 | 36869665 | PubTator, text mining | PubMed |
| Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach. | Clin Cancer Res | 2023 | 36862133 | PubTator, text mining | PubMed |
| Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapy. | Front Neurol | 2023 | 36846125 | PubTator, text mining | PubMed |
| Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy. | ESMO Open | 2023 | 36842301 | PubTator, text mining | PubMed |
| Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario. | Pharmaceutics | 2023 | 36839989 | PubTator, text mining | PubMed |
| Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre. | Int J Mol Sci | 2023 | 36835466 | PubTator, text mining | PubMed |
| Discovery of New Quinolone-Based Diarylamides as Potent B-RAFV600E/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity. | Int J Mol Sci | 2023 | 36834628 | PubTator, text mining | PubMed |
| Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications. | Cancers (Basel) | 2023 | 36831610 | PubTator, text mining | PubMed |
| Protein Kinase CK2 and Epstein-Barr Virus. | Biomedicines | 2023 | 36830895 | PubTator, text mining | PubMed |
| Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathway. | J Transl Med | 2023 | 36829235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=13